6
Frías Mena G y col. Uꢁlidad del análisis microbiológico de bilis en colecisꢁꢁs grado II. Rev Argent Cir. 2026;118(2):e-1813-bis
Discussion
Fiꢁy percent of paꢀents with posiꢀve cultures
had previously used PPIs; yet this difference was not
In grade II acute cholecysꢀꢀs, MBA did staꢀsꢀcally significant. Nevertheless, this finding elicits
not show posiꢀve results in most cases. The TG18 the need for further studies to shed light on the possible
2
menꢀoned posiꢀve cultures between 29% to 54% . In associaꢀon between the use of PPIs and changes in the
our experience, the percentage was lower (27%), as gallbladder microbiota in acute cholecysꢀꢀs.
was the case in other studies⁹, which may be due to
differences in the sample size. the low rate of bacteria isolated in bile cultures raises
a posiꢀve culture, the quesꢀons about the necessity of empirical anꢀbioꢀc
microorganisms were suscepꢀble to the empirical use in these paꢀents.
While this was not the objecꢀve of the study,
In cases with
treatment currently used by us. Gallbladder aspiraꢀon
Because the paꢀents received empirical
for microbiological analysis did not affect the anꢀbioꢀc therapy within the first hour aꢁer diagnosis,
approach to postoperaꢀve anꢀbioꢀc therapy. While the culture results may have been affected. However, this
the combinaꢀon of metronidazole and ceꢁriaxone is issue affected both groups to the same degree, and the
commonly used in our seꢄng due to the presumed laboratory was informed to take this factor into account
presence of anaerobic bacteria, their suscepꢀbility is during sample analyses. To minimize this bias, gallbladder
not assessed by anꢀmicrobial suscepꢀbility tesꢀng.
aspiraꢀon could have been performed before the
The most common resistance was to ampicillin, anꢀbioꢀcs were administered and surgery was performed.
an anꢀbioꢀc that is not included in the empirical However, this approach raises ethical quesꢀons.
treatment recommendaꢀons of our department or in
The MBA did not prolong hospital length of
2
the GT18 .
stay, as paꢀents were discharged based exclusively
Escherichia coli (28%), Enterobacter cloacae on their clinical progress. The culture results may
(
14%), and Streptococcus parasanguinis (14%) were be parꢀcularly relevant in cases with unfavorable
the bacteria most oꢁen isolated. Previous studies postoperaꢀve course.
conducted in Laꢀn America, as well as in other regions,
There were no changes in treatment duraꢀon
have also idenꢀfied Escherichia coli as the predominant or length of hospital stay among paꢀents with
pathogen, although with isolaꢀon rates exceeding posiꢀve cultures, as all isolated microorganisms were
,
,
4
5%³ ⁵ ⁶.
suscepꢀble to the empirical regimen used.
Gallbladder aspiraꢀon is a simple procedure
In this series, paꢀents with posiꢀve bile cultures
were significantly older than those with negaꢀve that does not prolong operaꢀve ꢀme. Furthermore,
cultures (57 vs. 44; p = 0.03). This finding aligns with the in certain situaꢀons, the controlled drainage of bile
established literature, which idenꢀfies advanced age as using this technique facilitates gallbladder retracꢀon,
an independent risk factor for bacterial colonizaꢀon which contributes to a safer and more effecꢀve
9
-11
of bile . This is likely due to immunosenescence, a cholecystectomy.
higher prevalence of comorbidiꢀes, and biliary ectasia
associated with anatomical and funcꢀonal changes design.
in the gallbladder. Further research could focus on
The limitaꢀon of this study is its single-center
In conclusion, because the bacteria isolated
from paꢀents who underwent surgery for grade
analyzing this subgroup of paꢀents.
Although we did not find a staꢀsꢀcally II cholecysꢀꢀs of GT18 were suscepꢀble to the
significant associaꢀon between the presence of empirical anꢀbioꢀc treatment, there is no raꢀonale for
comorbidiꢀes and MBA, BMI was high in 10 (71%) performing rouꢀne gallbladder aspiraꢀon during the
paꢀents with posiꢀve cultures.
procedure for MBA.
Referencias bibliográficas /References
1
2
3
4
.
.
.
.
Okamoto K, Suzuki K, Takada T, Strasberg SM, Asbun HJ, Endo
I, et al. Tokyo Guidelines 2018: flowchart for the management
of acute cholecysꢀꢀs. J Hepatobiliary Pancreat Sci [Internet].
for acute calculous cholecysꢀꢀs: Anꢀbioꢀc treatment for acute
calculous cholecysꢀꢀs. Br J Surg [Internet]. 2016;103(7):797-811.
Disponible en: hꢃp://dx.doi.org/10.1002/bjs.10146.
2
018;25(1):55-72. Disponible en: hꢃp://dx.doi.org/10.1002/
5. Granel-Villach L, Gil-Fortuño M, Fortea-Sanchis C, Gamón-
Giner RL, Marꢅnez-Ramos D, Escrig-Sos VJ. Factores que
influyen en la microbiología del líquido biliar en los pacientes
colecistectomizados. Rev Gastroenterol Méx (Engl Ed) [Internet].
2020;85(3):257-63. Disponible en: hꢃp://dx.doi.org/10.1016/j.
rgmx.2019.07.006.
jhbp.516.
Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T,
Strasberg SM, et al. Tokyo Guidelines 2018: anꢀmicrobial therapy
for acute cholangiꢀs and cholecysꢀꢀs. J Hepatobiliary Pancreat
Sci [Internet]. 2018;25(1):3-16. Disponible en: hꢃp://dx.doi.
org/10.1002/jhbp.518.
6. Gómez-Meléndez LJ, Acosta Pérez CA, Támara-Prieto JA,
Castellanos-Méndez JS, Márquez-Niño AI, Fernández-Ávila
DG. Caracterización de la flora bacteriana en los pacientes con
coleliꢀasis y colecisꢀꢀs atendidos en un centro hospitalario de
alta complejidad. Rev Colomb Cir [Internet]. 2022. Disponible en:
hꢃp://dx.doi.org/10.30944/20117582.2175.
Kujiraoka M, Kuroda M, Asai K, Sekizuka T, Kato K, Watanabe M, et
al. Comprehensive diagnosis of bacterial infecꢀon associated with
acute cholecysꢀꢀs using metagenomic approach. Front Microbiol
[
Internet]. 2017;8:685. Disponible en: hꢃp://dx.doi.org/10.3389/
fmicb.2017.00685.
van Dijk AH, de Reuver PR, Tasma TN, van Dieren S, Hugh TJ,
Boermeester MA. Systemaꢀc review of anꢀbioꢀc treatment
7. Yang M, Xia B, Lu Y, He Q, Lin Y, Yue P, et al. Associaꢀon between
regular use of gastric acid suppressants and subsequent risk